Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Rosso

Showing results (11-20 of 109) with videos related to

Pageof 11
Sort By:
Minerva Gastroenterology|June 3, 2021
Role of triglycerides to high-density lipoprotein cholesterol ratio in non-alcoholic fatty liver disease progressionChiara Rosso, Angelo Armandi, Aurora Nicolosi, et al.
Metabolism: Clinical and Experimental|November 21, 2024
An updated overview on hepatocellular carcinoma in patients with Metabolic dysfunction-Associated Steatotic Liver Disease: Trends, pathophysiology and risk-based surveillanceAngelo Armandi, Chiara Rosso, Gian Paolo Caviglia, et al.
Minerva Gastroenterology|September 11, 2023
Usefulness of Fibrosis-4 Index for the stratification of the risk of hepatocellular carcinoma development in patients with chronic hepatitis B on long-term follow-up: a single center experienceEleonora DI Leo, Chiara Rosso, Antonella Olivero, et al.
Panminerva Medica|October 19, 2020
Moving towards core antigen for the management of patients with overt and occult HBV infectionAngelo Armandi, Chiara Rosso, Davide G Ribaldone, et al.
Journal of Gastroenterology and Hepatology|February 22, 2013
Unconjugated bilirubin, a potent endogenous antioxidant, is decreased in patients with non-alcoholic steatohepatitis and advanced fibrosisFederico Salomone, Giovanni Li Volti, Chiara Rosso, et al.
Nutrients|February 13, 2025
Impact of Sexual Dimorphism on Therapy Response in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: From Conventional and Nutritional Approaches to Emerging TherapiesEleonora Dileo, Francesca Saba, Mirko Parasiliti-Caprino, et al.
Clinics and Research in Hepatology and Gastroenterology|January 14, 2021
Association between gut permeability and insulin resistance: Any role for zonulin in patients with non-alcoholic fatty liver disease?Chiara Rosso, Gian Paolo Caviglia, Angelo Armandi, et al.
Panminerva Medica|September 8, 2017
Liver fibrosis: the 2017 state of artGian P Caviglia, Chiara Rosso, Sharmila Fagoonee, et al.
Frontiers in Endocrinology|December 3, 2021
The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative ReviewAngelo Armandi, Chiara Rosso, Gian Paolo Caviglia, et al.
Diagnostics (Basel, Switzerland)|February 2, 2021
Hepatitis B Core-Related Antigen as Surrogate Biomarker of Intrahepatic Hepatitis B Virus Covalently-Closed-Circular DNA in Patients with Chronic Hepatitis B: A Meta-AnalysisGian Paolo Caviglia, Angelo Armandi, Chiara Rosso, et al.
Pageof 11

Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
Minerva Gastroenterology|June 3, 2021
Role of triglycerides to high-density lipoprotein cholesterol ratio in non-alcoholic fatty liver disease progressionChiara Rosso, Angelo Armandi, Aurora Nicolosi, et al.
Metabolism: Clinical and Experimental|November 21, 2024
An updated overview on hepatocellular carcinoma in patients with Metabolic dysfunction-Associated Steatotic Liver Disease: Trends, pathophysiology and risk-based surveillanceAngelo Armandi, Chiara Rosso, Gian Paolo Caviglia, et al.
Minerva Gastroenterology|September 11, 2023
Usefulness of Fibrosis-4 Index for the stratification of the risk of hepatocellular carcinoma development in patients with chronic hepatitis B on long-term follow-up: a single center experienceEleonora DI Leo, Chiara Rosso, Antonella Olivero, et al.
Panminerva Medica|October 19, 2020
Moving towards core antigen for the management of patients with overt and occult HBV infectionAngelo Armandi, Chiara Rosso, Davide G Ribaldone, et al.
Journal of Gastroenterology and Hepatology|February 22, 2013
Unconjugated bilirubin, a potent endogenous antioxidant, is decreased in patients with non-alcoholic steatohepatitis and advanced fibrosisFederico Salomone, Giovanni Li Volti, Chiara Rosso, et al.
Nutrients|February 13, 2025
Impact of Sexual Dimorphism on Therapy Response in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: From Conventional and Nutritional Approaches to Emerging TherapiesEleonora Dileo, Francesca Saba, Mirko Parasiliti-Caprino, et al.
Clinics and Research in Hepatology and Gastroenterology|January 14, 2021
Association between gut permeability and insulin resistance: Any role for zonulin in patients with non-alcoholic fatty liver disease?Chiara Rosso, Gian Paolo Caviglia, Angelo Armandi, et al.
Panminerva Medica|September 8, 2017
Liver fibrosis: the 2017 state of artGian P Caviglia, Chiara Rosso, Sharmila Fagoonee, et al.
Frontiers in Endocrinology|December 3, 2021
The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative ReviewAngelo Armandi, Chiara Rosso, Gian Paolo Caviglia, et al.
Diagnostics (Basel, Switzerland)|February 2, 2021
Hepatitis B Core-Related Antigen as Surrogate Biomarker of Intrahepatic Hepatitis B Virus Covalently-Closed-Circular DNA in Patients with Chronic Hepatitis B: A Meta-AnalysisGian Paolo Caviglia, Angelo Armandi, Chiara Rosso, et al.
Pageof 11